Form 4: Boxer Capital Management Sells 3,080,000 Shares of Tango Therapeutics

Sentiment:

SEC Form 4


Boxer Capital Management, a significant shareholder in Tango Therapeutics, sold 3,080,000 shares of common stock at an average price of $3.14 per share.

Summary

  • Boxer Capital Management, LLC, along with Aaron I. Davis, filed a Form 4 detailing changes in beneficial ownership of Tango Therapeutics, Inc. (TNGX) common stock.
  • On November 6, 2024, Boxer Capital Management sold 3,080,000 shares of common stock at a weighted average price of $3.14 per share.
  • The sales occurred in multiple transactions with prices ranging from $3.0000 to $3.3955.
  • Following the reported transaction, Boxer Capital Management indirectly holds 3,610,642 shares through an account managed by BCM.
  • MVA Investors, LLC, in which Aaron I. Davis is a member, directly owns 108,793 shares.
  • BCTG Holdings, LLC, in which MVA Investors is a member and Aaron I. Davis is on the investment committee, directly owns 6,988,450 shares.
  • The reporting persons may be deemed members of a group that formerly beneficially owned more than 10% of the outstanding shares of Tango Therapeutics' Common Stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the large sale of shares by a significant shareholder, which could indicate a lack of confidence or a change in investment strategy. However, without further context, it's difficult to assess the full impact.

Negatives

  • Boxer Capital Management, a significant shareholder, reduced its stake in Tango Therapeutics by selling 3,080,000 shares.

Risks

  • The sale of a large block of shares by a major shareholder like Boxer Capital Management could create downward pressure on the stock price.
  • The fact that the reporting persons may be deemed members of a group that formerly beneficially owned more than 10% of the outstanding shares of Tango Therapeutics' Common Stock may indicate a change in investment strategy.

Industry Context

Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. Large sales can sometimes indicate a change in sentiment or investment strategy, which other investors may consider.

Stakeholder Impact

  • Shareholders may react to the news of Boxer Capital Management's sale of shares, potentially leading to price volatility.
  • Employees may experience uncertainty if the sale signals a change in the company's prospects.

Key Dates

DateDescription
11/06/2024Date of the transaction where 3,080,000 shares of Common Stock were sold.
11/07/2024Date of signature for the Form 4 filing by Aaron I. Davis, Managing Member of Boxer Capital Management, LLC.
11/07/2024Date of signature for the Form 4 filing by Aaron I. Davis.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.